• A Billionaires Dying Wish A $10 Million Prize To Fight Brain Diseases

    Forbes | Named for late billionaire Richard Rainwater, the Rainwater Prize Program has launched to help find a cure for a rare brain disease.

    Nov 6, 2018

  • In conversation with… Harold Varmus

    Mosaic | Alok Jha talks to Harold Varmus, Nobel Prize-winning cancer researcher and current Director of the US National Cancer Institute.

    Nov 6, 2018

  • Illumina Acquires PacBio, Discusses Future In Investor Call

    Bio-IT World | Yesterday Illumina announced its intention to acquire Pacific Biosciences. Both companies presented the details and took questions during an investor call.

    Nov 2, 2018

  • New Head For Renamed Icahn Institute At Mount Sinai

    Bio-IT World | Mount Sinai has named a new head for its Icahn Institute, and renamed the effort the Icahn Institute for Data Science and Genomic Technology. Adam Margolin will lead the new enterprise-wide program, whose 10-year plan includes 55 new faculty and staff, new computational infrastructure, and an educational program to train master’s students and PhDs in biomedical data science.

    Nov 2, 2018

  • Illumina Buys PacBio For $1.2 Billion

    Bio-IT World News Brief | Illumina and Pacific Biosciences today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction. This price represents a premium of 71% to Pacific Biosciences’ 30 trading day volume weighted average share price as of the market close on October 31st, 2018, and a total enterprise value of approximately $1.2 billion on a fully diluted basis.

    Nov 1, 2018

  • 23andMe Test Cleared To Help Patients Determine How Well Drugs May Work For Them

    STAT | The genetic test is the first of its kind authorized by the Food and Drug Administration for direct-to-consumer marketing.

    Nov 1, 2018

  • QIAGEN, iSpecimen, Riffyn, And More: News From October 2018

    Bio-IT World | October featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including QIAGEN, iSpecimen, Riffyn, and more.

    Oct 31, 2018

  • How an outsider bucked prevailing Alzheimers theory clawed for validation

    STAT | Even as potential Alzheimer's drugs failed, researchers with fresh approaches struggled to get funded and to get studies published in top journals.

    Oct 29, 2018